Schiller India Leads the Diagnostic Backbone of Cipla’s First Lung Wellness Center 

Cipla has announced the launch of India’s first integrated Lung Health Diagnostics and Wellness Centre in New Delhi, an important milestone for respiratory care in the country. As the Breathefree Lung Wellness Center (BLWC) aims to close critical gaps in early detection and comprehensive lung evaluation, Schiller India is proud to support this initiative with our range of Respiratory Diagnostic devices. 

The newly launched centre features a full suite of SCHILLER’s premium diagnostic systems, enabling precise assessment across lung function, exercise physiology, and airway inflammation. The installation includes: 

• PowerCube Body+ – For complete lung volume and airway resistance measurement 
• CPET System – For detailed Cardiopulmonary exercise testing  
• SpiroScout – High-precision Ultrasonic Spirometry 
• NIOX® VERO – FeNO testing for airway inflammation 
• CARDIOVIT® AT-102 G2 – Resting ECG for Cardiopulmonary correlation 

By integrating over 60 tests covering lung physiology, microbiology, immunology, radiology, and blood chemistry, Cipla’s Breathefree Lung Wellness Center (BLWC) aims to bring holistic lung health assessment under one roof. Schiller India’s devices will play a vital role in delivering accurate, reliable, and clinically actionable diagnostics for patients across age groups and conditions. 

Schiller India remains committed to strengthening the respiratory ecosystem in India with high-quality, clinician-trusted diagnostic solutions.